Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-035005)

Filing Details

Accession Number:: 0001209191-14-035005
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-19 15:22:33
Reporting Period:: 2014-05-15

Filing Date:: 2014-05-19
Accepted Time:: 2014-05-19 15:22:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
938296	H Theodore Stanley	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-15	1,000	$20.99	3,100	No	4	P	Direct
Common Stock	Acquisiton	2014-05-15	1,000	$20.98	4,100	No	4	P	Direct
Common Stock	Acquisiton	2014-05-15	1,000	$20.97	5,100	No	4	P	Direct
Common Stock	Acquisiton	2014-05-19	1,000	$24.83	6,100	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

On March 28, 2014, the Issuer effected a 3-for-2 stock split, resulting in the reporting person's ownership of 700 additional shares of common stock.